Is 2026 the year that AI hype meets reality? In a new mini-series from Tech Tonic, the FT’s tech editor Murad Ahmed speaks with the paper’s reporters about what they'll be watching.

Do tech industry insiders think the huge amounts of capital that have driven the AI boom will continue? How will challenges to large-language model AI systems play out this year? And are chief executives expecting AI technologies to force job cuts?

In this episode, we hear from the FT’s venture capital correspondent George Hammond, AI correspondent Melissa Heikkilä and writer of the AI Shift newsletter Sarah O’Connor for their views on AI’s financial faultlines, how the technology will evolve and what kind of disruptions to expect in the world of work.

Free to read:

SpaceX, OpenAI and Anthropic prepare to launch landmark IPOs

Computer scientist Yann LeCun: ‘Intelligence really is about learning’

The AI Shift: Agentic AI is coming for quantitative research

Subscribe to The AI Shift newsletter, an essential deep-dive into how artificial intelligence is reshaping the world of work

This series of Tech Tonic is hosted by Murad Ahmed and produced by Josh Gabert-Doyon. The senior producer for Tech Tonic is Edwin Lane. Flo Phillips is the executive producer. Sound design by Breen Turner and Samantha Giovinco. Original music by Metaphor Music. Cheryl Brumley is the FT’s global head of audio.

The FT does not use generative AI to voice its podcasts.

A previous version of this podcast made a statement about Klarna's use of AI that the company has disputed. The reference has since been removed.

Hosted on Acast. See acast.com/privacy for more information.

Laura Hughes receives a tip that horses are dropping dead in Wales. As she investigates, she finds decades of academic studies researching the problem. She learns these aren’t isolated incidents. Something is spreading across the countryside. It’s undetectable to humans, nobody knows it’s there — until they fall ill. For more information on how to live safely with lead, please visit the LEAPP Alliance website.

To listen to the rest of the series, find Untold on your favourite podcast platform by clicking here!

Read a transcript of this episode on FT.com

Hosted on Acast. See acast.com/privacy for more information.

Gene and stem cell therapies have been touted as the next phase in the longevity movement, with promises to rejuvenate the body at the cellular level and reverse the effects of ageing. But, as the prospect of life extension moves into the mainstream, it presents big questions for society as a whole. Are we ready for a world where people live much longer lives?

In this final episode, the FT’s Michael Peel and Hannah Kuchler dive into the tough moral questions at the heart of the longevity movement. Hannah speaks to the team at Fountain Life, a longevity clinic trying to bring stem cell therapy to the middle classes. We meet Daniel Ives, founder of gene therapy company Shift Bioscience, and Liz Parrish, who has self-experimented with gene therapies through her company, Biovia. Finally, Michael speaks to Arthur Caplan, the head of the ethics board of longevity fund, Hevolution.

Free to read:

From immortal jellyfish to elephants: scientists probe secrets of long-lived animals

Inside the billion-dollar quest to live beyond 100

Gene editing breakthrough promises to boost fight against disease

This series of Tech Tonic is hosted by Michael Peel and Hannah Kuchler. It is produced by Josh Gabert-Doyon. The senior producer is Edwin Lane. Flo Phillips is the executive producer. Sound design by Breen Turner and Samantha Giovinco. Fact checking by Simon Greaves, Lucy Baldwin and Tara Cromie. Original music by Metaphor Music. Manuela Saragosa is the FT’s acting co-head of audio. Special thanks to Michela Tindera.

Clips: Al Jazeera Balkans, TV France Japon, ABP News, Rome Reports, @Sciencerely

The FT does not use generative AI to voice its podcasts.

Read a transcript of this episode on FT.com

Hosted on Acast. See acast.com/privacy for more information.

Singapore has become a model for longevity-focused healthcare. With an ageing population and citizens willing to spend money on anti-ageing treatments, the government and private companies are spending big on new ways to slow ageing, and help people live healthier for longer.

In this episode the FT’s Michael Peel visits the city-state to find out how longevity treatments are moving into the mainstream. He meets venture capitalist Boyang Wang, personal trainer Tiat Lim (‘Singapore’s Benjamin Button’), and longevity clinic founder Allen Law. Plus, we hear from Tan Kiat How, Singapore’s senior minister of state for health, and National University of Singapore professor Andrea Maier.

Free to read:

‘Can I lunge my way to eternal life?’

How one supplement sums up the uneasy science of selling youth

Singapore’s prime minister warns of ‘messy’ transition to post-American order

This series of Tech Tonic is hosted by Hannah Kuchler and Michael Peel. It is produced by Josh Gabert-Doyon. The senior producer is Edwin Lane. Flo Phillips is the executive producer. Sound design by Breen Turner and Samantha Giovinco. Fact checking by Simon Greaves, Lucy Baldwin and Tara Cromie. Original music by Metaphor Music. Manuela Saragosa is the FT’s acting co-head of audio. Special thanks to Owen Walker.

The FT does not use generative AI to voice its podcasts.

Clips: @channelnewsasia

To sign up for free to the new FT Alphaville newsletter on substack, go to ftav.substack.com

Read a transcript of this episode on FT.com

Hosted on Acast. See acast.com/privacy for more information.

How much do we really know about ageing? For decades, scientists have been trying to understand the biology of the ageing process - what happens to our bodies as we get older? And is it possible to slow that process down or even stop it all together?

In this series of Tech Tonic, the FT’s Hannah Kuchler and Michael Peel look into the past, present and future of longevity - the wellness movement focused on extending and bettering your quality of life. Episode 1 follows Hannah as she speaks with UCL professor David Gems about the history of ageing research, and then with longevity researcher Matt Kaeberlein to discuss how the industry has developed - including current drugs that could have anti-ageing effects. Plus, Michael visits the Reviv clinic in London where he experiences, first hand, the growing consumer interest in the longevity craze.

Read more from the FT — for free:

My year-long quest to live forever

The quest to make young blood into a drug

Muscly people show slower brain ageing, study finds

This season of Tech Tonic is presented by Hannah Kuchler and Michael Peel. It was produced by Josh Gabert-Doyon. The senior producer is Edwin Lane. Flo Phillips is the executive producer. Sound design by Breen Turner and Samantha Giovinco. Fact checking by Simon Greaves, Lucy Baldwin and Tara Cromie. Original music by Metaphor Music. Manuela Saragosa is the FT’s acting co-head of audio.

Clips: @DaveAspreyBPR, @drjoshaxe, @HealthCoachKait, Hevolution, Pom, Purina, Garnier, 4G antioxidants, @ChrisWillx, @lexfridman, ABC News, C-Span, CBS, ITV This Morning, Wired UK, The Dissenter, Will Tennyson

The FT does not use generative AI to voice its podcasts.

Read a transcript of this episode on FT.com

Hosted on Acast. See acast.com/privacy for more information.

Investors are spending billions of dollars on novel ways to extend human life through inventive treatments, therapies, and even manipulating our genes. And increasingly, it seems as though anti-ageing efforts have moved from the super rich to a mass market consumer industry. In this series, we’re covering the past, present and future of the longevity movement. We’ll be looking at where the fixation on longevity is coming from, and trying to understand the practical and ethical issues at the heart of this cutting-edge field of research.

From Silicon Valley fantasies, to Singaporean health spas, to Colombian genetic clinics and beyond, the FT’s Hannah Kuchler and Michael Peel ask whether breakthroughs in science and technology can really help us live longer, and even stop us aging altogether.

Free to read:

US ‘wellness’ industry scents opportunity to go mainstream

The quest to make young blood into a drug

This season of Tech Tonic was produced by Josh Gabert-Doyon. The senior producer is Edwin Lane. Flo Phillips is the executive producer. Sound design by Breen Turner and Samantha Giovinco. Fact checking by Simon Greaves, Lucy Baldwin and Tara Cromie. Original music by Metaphor Music. Manuela Saragosa is the FT’s acting co-head of audio.

The FT does not use generative AI to voice its podcasts.

Hosted on Acast. See acast.com/privacy for more information.

Introducing Toxic Legacy, a new season of Untold from the Financial Times. Host Laura Hughes uncovers a lead poisoning epidemic across the UK. You might be living with lead and not know it: the toxin is often invisible to the human eye, but wreaks havoc on our bodies once we’re exposed.

Listen on Apple Podcasts, Spotify, Pocket Casts or wherever you get your podcasts.

For information on how to live safely with lead, please visit the LEAPP Alliance website.

Hosted on Acast. See acast.com/privacy for more information.